Site Logo Delaware Health and Social Services

    Delaware Health Alert Notification #407

    Delaware Health Alert Notification #407

    Listen

    Delaware Health Alert Network #407

    June 13, 2019 2:13 pm

    Health

    Advisory

    DIVISION OF PUBLIC HEALTH INVESTIGATING TWO BRUCELLOSIS CASES LIKELY DUE TO CONSUMPTION OF DAIRY PRODUCTS MADE WITH UNPASTEURIZED MILK

    The Delaware Division of Public Health (DPH) is issuing this health advisory to increase awareness among

    health care providers on the risk of brucellosis associated with unpasteurized food sources. Two cases have

    been identified (one confirmed and one suspected) in Delaware from late May to early June 2019.

    Summary

    From late May 2019 to early June 2019, two cases of brucellosis (one confirmed and one suspected) have been

    identified in Delaware. These cases involve individuals from two separate households (familiar to each other),

    who consumed homemade unpasteurized dairy products from Mexico. The products were gifts, not purchased locally.

    The first case was identified as B. melitensis by the Centers for Disease Control and Prevention (CDC).

    Species identification of the second case is currently pending by the CDC. The principal hosts for B. melitensis

    are goats and sheep. This strain is also most pathogenic in humans and is most commonly related to consumption of

    unpasteurized dairy products from countries where the disease is present. Brucellosis is not common in the United States.

    Prior to these cases, in Delaware, DPH confirmed three cases since 2010 – one each in 2010, 2017, and 2018.

    The case in 2010 was associated with consumption of unpasteurized milk while the nature of exposure in the 2017 and

    2018 cases is unknown.

    Background

    Brucellosis is a bacterial infection caused by contact with infected animals or contaminated animal products.

    Infection is most commonly transmitted by eating or drinking unpasteurized/raw dairy products. Person-to-person

    spread of brucellosis is extremely rare. Infected mothers who are breast-feeding may transmit the infection to their

    infants. Sexual transmission has been rarely reported. While uncommon, transmission may also occur via tissue

    transplantation or blood transfusions.

    Symptoms of brucellosis include fever, sweats, malaise, anorexia, headache, fatigue, and muscle and joint pain.

    More serious presentations can include endocarditis, hepatomegaly, splenomegaly, and neurologic symptoms. In

    pregnant women, Brucella infections can be associated with miscarriage.

    Symptom onset can occur anywhere from five days to six months following exposure.

    Recommendations for Patients with Suspected Infection

    Health care providers caring for febrile patients who live in, or have recently traveled to, a country where

    brucellosis is endemic should consider brucellosis among their differential diagnoses. It is also important to

    inquire about activities related to risk factors to more precisely assess the risk of exposure. Questions about

    risk factors may include:

    •  Travel history – a list of countries where there is an increased risk of brucellosis can be foundhere: https://www.cdc.gov/brucellosis/exposure/areas.html
    •  Consumption of unpasteurized dairy products or undercooked meat
    •  Occupational or recreational exposures such as working in a laboratory, work in a slaughterhouse ormeatpacking industry, hunting and assisting animals with the birthing process.

    Diagnosis

    Isolation and identification of Brucella can confirm a diagnosis of brucellosis. Brucella is

    most commonly isolated from blood cultures.

    When sending specimens to a laboratory for culture and isolation, be sure the laboratory is aware of your suspected

    diagnosis. Breathing in the bacteria that causes brucellosis may also lead to infection. This risk is generally greater

    for people in laboratories that work with the bacteria.

    Treatment

    Generally, doxycycline and rifampin are recommended in combination for a minimum of six to eight weeks for confirmed

    cases of brucellosis.

    Reporting

    Brucellosis is a reportable disease in Delaware. All Delaware health care providers and laboratories are required by

    regulation to report patients with known or suspected brucellosis.

    How to Report

    Immediately contact the DPH Office of Infectious Disease Epidemiology (888-295-5156, 24/7) of any known or suspected

    brucellosis case.

    Additional Information

    CDC: https://www.cdc.gov/brucellosis/index.html

    ************************************

    You are receiving this email because you are a registered member of the Delaware Health Alert Network.

    If you are not a member and would like to subscribe, please register at https://healthalertde.org

    Categories of Health Alert messages:

    • Health Alert: Conveys the highest level of importance; warrants immediate action or attention.
    • Health Advisory: Provides important information for a specific incident or situation; may not require immediate action.
    • Health Update: Provides updated information regarding an incident or situation; unlikely to require immediate action.
    NOTE: This page is for informational purposes only and dated material (e.g. temporary websites) may not be available.